1. Market Research
  2. > Pharmaceutical
  3. > Drug Discovery and Development Market Trends
  4. > Cervical Dysplasia Global Clinical Trials Review, H2, 2015

Cervical Dysplasia Global Clinical Trials Review, H2, 2015

Summary

GlobalData's clinical trial report, “Cervical Dysplasia Global Clinical Trials Review, H2, 2015" provides an overview of Cervical Dysplasia clinical trials scenario. This report provides top line data relating to the clinical trials on Cervical Dysplasia. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Global Data Clinical Trial Reports are generated using Global Data’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table Of Contents

Cervical Dysplasia Global Clinical Trials Review, H2, 2015
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Cervical Dysplasia 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Cervical Dysplasia to Women's Health Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Cervical Dysplasia to Women's Health Clinical Trials 18
Clinical Trials by Phase 19
In Progress Trials by Phase 20
Clinical Trials by Trial Status 21
Clinical Trials by End Point Status 22
Unaccomplished Trials of Cervical Dysplasia 23
Subjects Recruited Over a Period of Time 25
Clinical Trials by Sponsor Type 26
Prominent Sponsors 27
Top Companies Participating in Cervical Dysplasia Therapeutics Clinical Trials 28
Prominent Drugs 29
Clinical Trial Profiles 30
Clinical Trial Overview of Top Companies 30
GenoLac BL Corporation 30
Clinical Trial Overview of GenoLac BL Corporation 30
AnGes MG, Inc. 31
Clinical Trial Overview of AnGes MG, Inc. 31
Merck Sharp and Dohme Corp. (Inactive) 32
Clinical Trial Overview of Merck Sharp and Dohme Corp. (Inactive) 32
Merck and Co., Inc. 33
Clinical Trial Overview of Merck and Co., Inc. 33
Kirax Corporation 34
Clinical Trial Overview of Kirax Corporation 34
Inovio Pharmaceuticals, Inc. 35
Clinical Trial Overview of Inovio Pharmaceuticals, Inc. 35
CEL-SCI Corporation 36
Clinical Trial Overview of CEL-SCI Corporation 36
Bioleaders Corporation 37
Clinical Trial Overview of Bioleaders Corporation 37
Eisai Co., Ltd. 38
Clinical Trial Overview of Eisai Co., Ltd. 38
Akela Pharma Inc. (Inactive) 39
Clinical Trial Overview of Akela Pharma Inc. (Inactive) 39
Clinical Trial Overview of Top Institutes / Government 40
Maastricht University Medical Center 40
Clinical Trial Overview of Maastricht University Medical Center 40
Medical University of Vienna 41
Clinical Trial Overview of Medical University of Vienna 41
The National Institute of Allergy and Infectious Diseases 42
Clinical Trial Overview of The National Institute of Allergy and Infectious Diseases 42
The University of Tokyo Hospital 43
Clinical Trial Overview of The University of Tokyo Hospital 43
Center for Genetic Engineering and Biotechnology 44
Clinical Trial Overview of Center for Genetic Engineering and Biotechnology 44
Centre Hospitalier Regional Universitaire de Tours 45
Clinical Trial Overview of Centre Hospitalier Regional Universitaire de Tours 45
Chiang Mai University 46
Clinical Trial Overview of Chiang Mai University 46
Christine Fromer-Stiftung 47
Clinical Trial Overview of Christine Fromer-Stiftung 47
Dana-Farber Cancer Institute, Inc. 48
Clinical Trial Overview of Dana-Farber Cancer Institute, Inc. 48
Department of Health, South Africa 49
Clinical Trial Overview of Department of Health, South Africa 49
Five Key Clinical Profiles 50
Appendix 86
Abbreviations 86
Definitions 86
Research Methodology 87
Secondary Research 87
About GlobalData 88
Contact Us 88
Disclaimer 88
Source 89

List of Tables
Cervical Dysplasia Therapeutics, Global, Clinical Trials by Region, 2015* 7
Cervical Dysplasia Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Cervical Dysplasia Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Cervical Dysplasia Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2015* 10
Cervical Dysplasia Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 11
Cervical Dysplasia Therapeutics Clinical Trials, North America, Top Countries, 2015* 12
Cervical Dysplasia Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2015* 13
Cervical Dysplasia Therapeutics Clinical Trials, Central and South America, Top Countries, 2015* 14
Proportion of Cervical Dysplasia to Women's Health Clinical Trials, G7 Countries (%), 2015* 15
Cervical Dysplasia Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16
Cervical Dysplasia Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17
Proportion of Cervical Dysplasia to Women's Health Clinical Trials, E7 Countries (%), 2015* 18
Cervical Dysplasia Therapeutics, Global, Clinical Trials by Phase, 2015* 19
Cervical Dysplasia Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 20
Cervical Dysplasia Therapeutics, Global, Clinical Trials by Trial Status, 2015* 21
Cervical Dysplasia Therapeutics Clinical Trials, Global, by End Point Status, 2015* 22
Cervical Dysplasia Therapeutics, Global, Withdrawn Clinical Trials, 2015* 23
Cervical Dysplasia Therapeutics, Global, Terminated Clinical Trials, 2015* 24
Cervical Dysplasia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 25
Cervical Dysplasia Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 26
Cervical Dysplasia Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 27
Cervical Dysplasia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 28
Cervical Dysplasia Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 29
Cervical Dysplasia Therapeutics Clinical Trials Market, Global, Clinical Trials by GenoLac BL Corporation, 2015* 30
Cervical Dysplasia Therapeutics Clinical Trials Market, Global, Clinical Trials by AnGes MG, Inc., 2015* 31
Cervical Dysplasia Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck Sharp and Dohme Corp. (Inactive), 2015* 32
Cervical Dysplasia Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck and Co., Inc., 2015* 33
Cervical Dysplasia Therapeutics Clinical Trials Market, Global, Clinical Trials by Kirax Corporation, 2015* 34
Cervical Dysplasia Therapeutics Clinical Trials Market, Global, Clinical Trials by Inovio Pharmaceuticals, Inc., 2015* 35
Cervical Dysplasia Therapeutics Clinical Trials Market, Global, Clinical Trials by CEL-SCI Corporation, 2015* 36
Cervical Dysplasia Therapeutics Clinical Trials Market, Global, Clinical Trials by Bioleaders Corporation, 2015* 37
Cervical Dysplasia Therapeutics Clinical Trials Market, Global, Clinical Trials by Eisai Co., Ltd., 2015* 38
Cervical Dysplasia Therapeutics Clinical Trials Market, Global, Clinical Trials by Akela Pharma Inc. (Inactive), 2015* 39
Cervical Dysplasia Therapeutics Clinical Trials Market, Global, Clinical Trials by Maastricht University Medical Center, 2015* 40
Cervical Dysplasia Therapeutics Clinical Trials Market, Global, Clinical Trials by Medical University of Vienna, 2015* 41
Cervical Dysplasia Therapeutics Clinical Trials Market, Global, Clinical Trials by The National Institute of Allergy and Infectious Diseases, 2015* 42
Cervical Dysplasia Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Tokyo Hospital, 2015* 43
Cervical Dysplasia Therapeutics Clinical Trials Market, Global, Clinical Trials by Center for Genetic Engineering and Biotechnology, 2015* 44
Cervical Dysplasia Therapeutics Clinical Trials Market, Global, Clinical Trials by Centre Hospitalier Regional Universitaire de Tours, 2015* 45
Cervical Dysplasia Therapeutics Clinical Trials Market, Global, Clinical Trials by Chiang Mai University, 2015* 46
Cervical Dysplasia Therapeutics Clinical Trials Market, Global, Clinical Trials by Christine Fromer-Stiftung, 2015* 47
Cervical Dysplasia Therapeutics Clinical Trials Market, Global, Clinical Trials by Dana-Farber Cancer Institute, Inc., 2015* 48
Cervical Dysplasia Therapeutics Clinical Trials Market, Global, Clinical Trials by Department of Health, South Africa, 2015* 49

List of Figures
Cervical Dysplasia Therapeutics, Global, Clinical Trials by Region (%), 2015* 7
Cervical Dysplasia Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Cervical Dysplasia Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Cervical Dysplasia Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2015* 10
Cervical Dysplasia Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015* 11
Cervical Dysplasia Therapeutics Clinical Trials, North America, Top Countries (%), 2015* 12
Cervical Dysplasia Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2015* 13
Cervical Dysplasia Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2015* 14
Proportion of Cervical Dysplasia to Women's Health Clinical Trials, G7 Countries (%), 2015* 15
Cervical Dysplasia Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16
Cervical Dysplasia Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17
Proportion of Cervical Dysplasia to Women's Health Clinical Trials, E7 Countries (%), 2015* 18
Cervical Dysplasia Therapeutics, Global, Clinical Trials by Phase (%), 2015* 19
Cervical Dysplasia Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 20
Cervical Dysplasia Therapeutics, Global, Clinical Trials by Trial Status, 2015* 21
Cervical Dysplasia Therapeutics Clinical Trials, Global, by End Point Status, 2015* 22
Cervical Dysplasia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 25
Cervical Dysplasia Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 26
Cervical Dysplasia Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 27
Cervical Dysplasia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 28
Cervical Dysplasia Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 29
GlobalData Methodology 87

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

  • $ 5650
  • Industry report
  • August 2016
  • by MarketsandMarkets

The global clinical trial management system (CTMS) market is estimated to grow at a CAGR of 11.5% from 2016 to 2021, to reach USD 920.0 billion by 2021. The adoption of CTMS software is on the rise across ...

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The global CRO services market is estimated to grow at a CAGR of 7.4% from 2016 to 2021, to reach USD 41.86 billion by 2021 from USD 29.29 billion in 2016. Growth in this market is primarily attributed ...

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • November 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Clinical Trial Management System (CTMS) market is expected to grow from $493.58 million in 2015 to reach $1118.58 million by 2022 with a CAGR of 12.4%. Huge research ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.